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METHODS ARTICLE
A Method for Identifying Mouse Pancreatic Ducts
Chiemi Nakajima, BS,1 Kenji Kamimoto, PhD,2 Katsuhiro Miyajima, PhD,1 Masahito Matsumoto, PhD,3
Yasushi Okazaki, MD, PhD,3,4 Kazuo Kobayashi-Hattori, PhD,5 Makoto Shimizu, PhD,5
Takumi Yamane, PhD,1 Yuichi Oishi, PhD,1 and Ken Iwatsuki, PhD1
Proper identification of pancreatic ducts is a major challenge for researchers performing partial duct ligation (PDL),
because pancreatic ducts, which are covered with acinar cells, are translucent and thin. Although damage to pancreatic
ducts may activate quiescent ductal stem cells, which may allow further investigation into ductal stem cells for
therapeutic use, there is a lack of effective techniques to visualize pancreatic ducts. In this study, we report a new
method for identifying pancreatic ducts. First, we aimed to visualize pancreatic ducts using black, waterproof fountain
pen ink. We injected the ink into pancreatic ducts through the bile duct. The flow of ink was observed in pancreatic
ducts, revealing their precise architecture. Next, to visualize pancreatic ducts in live animals, we injected fluorescein-
labeled bile acid, cholyl-lysyl-fluorescein into the mouse tail vein. The fluorescent probe clearly marked not only the
bile duct but also pancreatic ducts when observed with a fluorescent microscope. To confirm whether the pancreatic
duct labeling was successful, we performed PDL on Neurogenin3 (Ngn3)-GFP transgenic mice. As a result, acinar
tissue is lost. PDL tail pancreas becomes translucent almost completely devoid of acinar cells. Furthermore, strong
activation of Ngn3 expression was observed in the ligated part of the adult mouse pancreas at 7 days after PDL.
Keywords: partial duct ligation, stem cells, differentiation, Ngn3
Impact Statement
Although the result of partial duct ligation (PDL) provides us with an excellent model for pancreas regeneration after the
injury, the technique involves ligation of a small portion of the tissue so that the results of PDL often varies experiment to
experiment, leading researchers inconsistent conclusions. The main reason for this is that pancreatic ducts are thin and
translucent. In addition, there are chances to ligate blood vessels together with pancreatic ducts that make the result more
complicated. We therefore tried to find a way of labeling pancreatic ducts and finally found a simple method to fluorescently
label them in live animals. Using this method, we have increased the success rate of PDL and therefore could obtain
reproducible results in regeneration studies.
Introduction
More than 420 million people suffer from diabetesworldwide.1 Slowing the increasing prevalence of
diabetes is a major challenge in the medical field, because
no effective drug presently exists. Transplantation of pan-
creatic islets is a reliable diabetes treatment that is presently
available.2,3 Islets can be generated from pancreatic pro-
genitor cells that emerge when the tissue is damaged.
However, where these progenitor cells reside remains con-
troversial.4–8 It is generally thought that beta cell growth
occurs only by self-renewal of mature beta cells under
normal physiological conditions.9–11 In other studies, it has
been reported that beta cell progenitors can be generated by
partial duct ligation (PDL) in adult mice.12–14 The procedure
involves ligation of the pancreatic duct that drains pancre-
atic enzymes into the duodenum. This ligation model could
be a valid analytical tool to study the mechanism of pan-
creatic beta cell neogenesis. However, the outcomes of
studies using the ligation technique appear to vary across
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laboratories; some groups show that ‘‘the response to PDL
induces not only measurable but also large increases in beta
cell mass,’’6,12–17 whereas the other group observed that
‘‘there is no solid evidence that new beta cells occurred in
PDL pancreas.’’18–20 Although De Groef et al. established
the PDL surgical procedure,21 the success rate of ligation
varied from experiment to experiment. The main reason for
this is that the pancreatic duct is thin and often difficult to
identify. To overcome this problem, methods to precisely
identify and ligate pancreatic ducts are necessary. Further-
more, visualizing pancreatic ducts greatly enhances our
ability to study the role of pancreatic ducts in numerous
aspects of pancreatic growth, development, and function. To
identify pancreatic ducts, Guo et al. described ductal la-
beling methods using a recombinant adeno-associated virus
with a duct-specific Sox9 promoter infused into mouse
pancreatic ducts.22 However, there is no report for a sim-
plified method to identify pancreatic ducts in native tissues.
In this study, we report a new, simple labeling technique
to reveal the architecture of mouse pancreatic ducts. Using
this method, we generated a PDL model and observed the
same results as previous reports such as loss of acinar cells
and ductal neogenesis.13,14,21 Moreover, upregulation of
Ngn3 (neurogenin3), a well-established endocrine cell marker23
and a well-established marker for embryonic islet cell pro-




All animals used in this study were obtained, housed,
cared for, and used in accordance with the ‘‘Guiding Prin-
ciples in the Care and Use of Animals’’ published by the
Animal Care Committee of Tokyo University of Agriculture
(Ethics identification number: 140014). Wild-type C57BL/
6J mice and Jcl: ICR mice were purchased from CLEA
Japan (Tokyo, Japan). The Ngn3-GFP mice were backcrossed
(for eight generations) using a C57BL/6 background. The
Ngn3-GFP mouse has been described previously.26 Animals
were maintained in a 12 h light cycle providing food and
water ad libitum.
Visualizing mouse pancreatic ducts using black ink
Sodium pentobarbital was purchased from Kyoritsu
Seiyaku Corporation (Tokyo, Japan). SPC-200, black, wa-
terproof, fountain pen ink was purchased from Platinum
Japan Corporation (Tokyo, Japan). Microhematocrit capil-
lary tubes (22-362-566) were purchased from Fisher Sci-
entific Corporation (Tokyo, Japan). Fine glass capillaries
were made by stretching heated microhematocrit tubes.
Then, a 1 mL syringe was connected to a glass capillary
through a silicon tube. Adult mice were sacrificed by ex-
cessive anesthesia (sodium pentobarbital anesthesia at a
dose of 100 mg/kg body weight) and subjected to laparot-
omy. The spleen, the stomach, and the duodenum were re-
moved using sterile tweezers or swab, according to the
method of De Groef et al.21 Pancreatic ducts branch from
the bile duct, and the bile duct flows into the duodenum. We
transferred the intestinal wall with a microhematocrit cap-
illary tube slowly to locate the papilla of Vater, then injected
10–15 mL of undiluted SPC-200 ink, slowly into the bile
duct retrogradely, as described in recent studies.27 The ink
was infused onto the bile duct and the pancreatic duct through
the papilla of Vater (Fig. 1A).
Labeling of pancreatic ducts using a fluorescent
reagent and PDL
Chlorhexidine gluconate was purchased from Sumitomo
Dainippon Pharma (Osaka, Japan). Pentobarbital sodium
was purchased from Kyoritsu Seiyaku Corporation. Cholyl-
lysyl-fluorescein (CLF) was purchased from CORNING
(Woburn). CLF is a fluorescent bile salt whose biological
behavior closely resembles that of naturally occurring cho-
lylglycine and is a potential agent for assessing liver func-
tion in vivo.28 CLF fluorescently labels the bile duct.
According to the previous report, intestinal uptake of CLF
was negligible when compared with taurocholate in mice,
because absorbed CLF is transported back into the blood
stream by the ABCC3 transporter.29 Enterohepatic circula-
tion of CLF is reabsorbed into the portal vein and then dis-
charged. All dissecting instruments were sterilized by 0.5%
chlorhexidine gluconate to minimize infection. A heating pad
was provided at of 38C for temperature stabilization during
surgery. The animals (Jcl: ICR mice) were dissected under
sodium pentobarbital anesthesia at a dose of 30 mg/kg body
FIG. 1. Visualization of pancreatic ducts using black ink.
(A) Schematic figure of the mouse gut and site of ink in-
jection. Black waterproof fountain pen ink (SPC-200) was
injected into the pancreatic ducts through the bile duct. (B)
Pancreatic ducts (white arrows) became visible after black
ink injection. Scale bar, 2 mm.
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weight and put into an adjuster. Then, animals were injected
with CLF (100mg/mL) at a dose of 350mg/kg body weight by
tail vein injection (Fig. 2A). After 10 min, a laparotomy was
performed through a midline abdominal incision. The spleen,
the stomach, and the duodenum were removed as described
above. The pancreatic duct visualized by the fluorescent
substance using a stereoscopic microscope was ligated at the
tail region using a sterilized thread. Ligation was performed to
minimize damage to the underlying blood vessels, such as the
superior pancreaticoduodenal artery, the inferior pancreatico-
duodenal artery, and the pancreatic part of the splenic artery.
The incision was sewn up, and the mouse was placed in the
warm recovery area. At 1, 3, and 14 days after CLF admin-
istration (n = 3, respectively), the pancreas, liver, duodenum,
kidney, and spleen were fixed with 4% paraformaldehyde
(PFA), and the tissues were paraffin-embedded using stan-
dard techniques, and thin sections were made (3–5mm). The
sections were stained with hematoxylin and eosin (HE).
HE-stained samples were examined histopathologically. At
7 days after CLF administration, total protein, albumin, al-
anine aminotransferase, total cholesterol, triglyceride, bile
acid, and total bilirubin in sera were biochemically mea-
sured by Oriental Yeast (Tokyo, Japan).
Immunohistochemistry
Antibodies used were rat anti-mouse CD326 (BD Bio-
science, Tokyo, Japan), rabbit antiamylase (ab21156), goat
anti-PDX1 (ab47383; Abcam, Cambridge, United Kingdom),
and goat anti-GFP (ROCKLAND, Limerick, Ireland). Rabbit
anti-CK19 antibodies were a gift from Prof. Atsushi Miyaji-
ma.27,30 Seven days after PDL administration, Ngn3-GFP
mice (n = 3) were infused with 10 mL phosphate-buffered
saline (PBS) followed by 10 mL 4% PFA in PBS, using a
peristaltic pump (ATTO, Tokyo, Japan). The pancreatic tis-
sues were then harvested and fixed for 2 h at 4C in 4% PFA
in PBS, transferred to 30% sucrose in PBS, and stored at 4C
overnight. Tissues were dissected and embedded in O.C.T
compound (Sakura Finetek Japan). Then, 12mm frozen sec-
tions were prepared and incubated in 0.3% Triton X-100 and
2% donkey serum for 1 h at room temperature. The primary
antibodies were added to the section in a humidified
chamber and incubated overnight at 4C. Sections were
washed in PBS, incubated with the secondary antibodies
(Alexa Fluor 555 or 594 IgG against primary antibodies
from Invitrogen, Tokyo, Japan) for 1 h, and rinsed in PBS.
For counterstaining, nuclei were labeled with DAPI (Nacalai
Tesque, Kyoto, Japan).
Results
Visualization of mouse pancreatic ducts using black ink
By injecting black ink into the bile duct through the du-
odenum and the papilla of Vater (Fig. 1A), both the bile duct
and pancreatic ducts of the head and tail region were clearly
labeled (Fig. 1B). As translucent pancreatic ducts became
obvious, the main pancreatic ducts as well as fine pancreatic
ducts could be identified (white arrowheads in Fig. 1B).
Therefore, by ink injection, the precise architecture of the
mouse pancreatic ducts was revealed.
Visualization of pancreatic ducts using
a fluorescent probe
Although the ink injection strategy allowed us to identify
pancreatic ducts, we next screened for chemicals that are not
harmful to the animal, so that it could be used in live ani-
mals. We found the candidate compound CLF, which is a
fluorescently labeled analog of bile acid. After administra-
tion of CLF through the tail vein, we observed that this
fluorescent probe labeled the bile duct. Furthermore, CLF
also labeled pancreatic ducts (Fig. 2B, C). Using this
method, both head and tail pancreatic ducts were clearly
visualized in live animals. To fully understand this method
for visualizing pancreatic ducts, we investigated whether
this method affects any other organs and tissues. The results
of the histopathological observation revealed that there were
no abnormalities in any other tissues in all animals, including
1, 3, and 14 days after the operation (n = 3; Supplementary
Fig. S1; Supplementary Data are available online at www
.liebertpub.com/tec). Biochemical assay using sera showed
FIG. 2. Visualizing pan-
creatic ducts after fluorescent
probe injection. (A) Mice
were injected with CLF
(100mg/mL) at a dose of
350 mg/kg body weight by
tail vein injection. (B,C) CLF
clearly marked not only the
bile duct (black arrows) but
also pancreatic ducts (white
arrows) under the fluorescent
microscope. C is an image of
the underside of B. Scale bar,
2 mm. CLF, cholyl-lysyl-
fluorescein.
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no significant damage of tissues by CLF administration
(Supplementary Table S1).
PDL operation after CLF injection
To examine if the use of our new CLF duct visualization
method increases success rates of PDL, we performed PDL
on Ngn3-GFP reporter mice. The transgenic mice express a
GFP reporter gene under the control of a Ngn3 promoter.
We detected GFP signal in enteroendocrine cells of the
duodenum, jejunum, and stomach where Ngn3 expression
has been reported31 (Supplementary Fig. S2A–C). In normal
condition, GFP signal could not be detected in the pancreas
of Ngn3-GFP mice (Supplementary Fig. S2D). After PDL
operation, GFP reporter signals were observed around out-
side of the ductal lining.
The pancreatic duct draining the exocrine enzymes from
the tail of the pancreas was ligated while the organ’s head,
located adjacent to the stomach and duodenum, remained
unaffected. The ligature is applied downstream of the
splenic part or tail of the pancreas, referred to as the ‘‘PDL
tail.’’ As has been previously reported,21 PDL seemed to
induce inflammation and acinar cell atrophy resulting a
gradual loss of acinar tissue. In contrast, acinar cell death
does not occur in the ‘‘head’’ region of the PDL pancreas.
Age-matched male or female mice underwent sham surgery,
recapitulating all steps of PDL surgery, except the ligation
of the pancreatic duct. Pancreatic tissues were harvested
7 days postsurgery. Using this new visualizing method, al-
most all PDLs were performed correctly. Success rate of the
PDL with a new method was 88% (22 successes out of 25
trials) while 10% (1 success out of 10 trials) with a con-
ventional method. When the tail pancreatic PDL was per-
formed, acinar cells were depleted, making the PDL tail
pancreas translucent (Fig. 3B, C). Depletion of acinar cells
was also confirmed by detecting amylase, an acinar cell
marker (Fig. 3D, E, Supplementary Fig. S5), and by
hematoxylin-eosin staining (data not shown). Furthermore,
ductal reconstruction was observed in the PDL section as
detected by CK19 antibodies (Fig. 3F, G). Interestingly,
Ngn3 expression was upregulated during pancreatic regen-
eration followed by PDL. A strong Ngn3 signal represented
FIG. 3. Partial duct ligation using the CLF visualizing method. (A) A schematic representation of the ligation site and the
result of PDL. The pancreatic duct labeled by CLF was ligated at the tail region. (B, C) Representative photos of the
pancreas 7 days after PDL (n = 3). Acinar cells of the tail region became translucent as a result of autolysis after ligation (C,
dotted circle). Scale bar, 2 mm. (D–J) Immunohistochemical analysis of the PDL-treated pancreas with sham-operated
tissue serving as a control. (D, E) Amylase immunoreactivity was observed from the sham-operated tail region of the
pancreas (D), while most of amylase positive cells were gone at Day 7 after PDL operation (E). (F, G) Upregulation of
CK19 expression (white arrowheads) was observed in the PDL tissue section, indicating ductal neogenesis. (H, I) CD326, a
general epithelial marker was detected in both ductal and acinar cells of sham tissue, but could be detected only from ductal
cells after PDL operation. (I, J) A strong but specific expression of Ngn3-GFP (white arrowheads) was observed peripheral
to the pancreatic ducts of the PDL pancreas. Scale bars: D, E, H–J, 100mm and F, G, 250mm. Ngn3, neurogenin3; PDL,
partial duct ligation.
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by GFP expression was observed outside lining of the
CD326 and CK19 positive ductal markers 7 days postsurgery
(Fig. 3I, J, Supplementary Fig. S3). We failed to detect any
GFP signal in sham-operated pancreas of Ngn3-GFP mice
(Fig. 3H). We have verified that green fluorescent signals
from Ngn3-GFP mice are derived from GFP using anti-GFP
antibodies (Supplementary Fig. S4, top panels). These data
suggest that Ngn3+ cells originate from pancreatic ductal cells.
Discussion
In this study, we demonstrated a new, simple imaging
technique to reveal the architecture of mouse pancreatic
ducts using both black waterproof fountain pen ink and the
fluorescein-labeled bile acid analog CLF. Both reagents
clearly labeled pancreatic ducts as well as the bile duct and
allowed us to track major ducts. By using CLF as an arti-
ficial bile acid, we succeeded in labeling pancreatic ducts in
real time, low invasively. Accordingly, the visualized pan-
creatic duct could be ligated at the intended position, and
PDL was pathologically and histologically confirmed after 1
and 2 weeks. Thus, we have established a new technique for
PDL using this simple imaging technique. As described
earlier, there are contradictory results over the exact origin
of these progenitor cells.4,32 There are at least three models
to explain regenerative activities of islets. The first model
shows that adult pancreatic cells produce progenitor cells
upon injury. In this model, pancreatic duct cells obtain
ability to differentiate into both endocrine and exocrine
cells.5,6 The second model suggests self-duplication of adult
pancreatic beta-cells.7 The third model utilizes acinar cells
to obtain transdifferentiation activities.8 These discrepancies
could be attributed to a combination of factors such as
bodyweight, sex, and age of the mice, but, most importantly,
differences in surgical technique.11,21 Since pancreatic ducts
cannot easily be identified, ligating the pancreatic duct may
result in ligation of some blood vessels as well. These sur-
gical complications may be the source of outcome variation.
Because our new method does not require any special tech-
niques and is highly reproducible, we believe our method
could overcome these previous complications.
In the present study, we utilized Ngn3-GFP reporter mice
to determine whether GFP-marked pancreas progenitor cells
appear after PDL. It has been reported that Ngn3 expression
is detected in enteroendocrine progenitor cells in the stom-
ach and small intestines.31 After PDL was performed, our
samples became devoid of acinar cells and ductal neogen-
esis could be observed, accompanied by upregulation of
Ngn3 expression proximal to pancreatic ducts. Our results
are consistent with the previous work by Xu et al., sug-
gesting that Ngn3+ cells originate from pancreatic ductal
cells.13 Other transcription factor reporter mice, such as
Nkx6.133 and MafA,34 could serve as beneficial tools in
investigating pancreatic cell differentiation and determining
the origin of pancreatic progenitor cells after lesioning of
the pancreas.
In conclusion, the newly established method for imaging
the pancreatic duct has potential to provide an excellent
model for pancreatic regeneration and differentiation, to
assist for the fundamental understanding of the mechanism
of pancreatic stem/progenitor cells to benefit future thera-
pies and drug screening.
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